PetVivo Holdings's book value per share for the quarter that ended in Dec. 2023 was $0.06.
During the past 12 months, PetVivo Holdings's average Book Value Per Share Growth Rate was -23.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of PetVivo Holdings was 73.90% per year. The lowest was -229.90% per year. And the median was 11.65% per year.
PetVivo Holdings's current price is $0.7203. Its book value per share for the quarter that ended in Dec. 2023 was $0.06. Hence, today's PB Ratio of PetVivo Holdings is 12.01.
During the past 13 years, the highest P/B Ratio of PetVivo Holdings was 314.18. The lowest was 1.71. And the median was 44.44.
PetVivo Holdings Book Value per Share Historical Data
The historical data trend for PetVivo Holdings's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PetVivo Holdings's Book Value per Share
For the Medical Devices subindustry, PetVivo Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetVivo Holdings's PB Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where PetVivo Holdings's PB Ratio falls into.
PetVivo Holdings Book Value per Share Calculation
PetVivo Holdings's Book Value Per Share for the fiscal year that ended in Mar. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
PetVivo Holdings (OTCPK:PETV) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
PetVivo Holdings Book Value per Share Related Terms
Thank you for viewing the detailed overview of PetVivo Holdings's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
PetVivo Holdings (PetVivo Holdings) Business Description
PetVivo Holdings Inc is an emerging biomedical device company. The group is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. A key strategy of the company is to leverage human therapies for the treatment of companion animals cost-effectively and in a timely manner. The accelerated timeline to revenues for veterinary medical devices is a key component of this strategy, which enter the market much earlier than pharmaceuticals and biologics. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of nineteen patents.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PETV has been successfully added to your 